Back to companies

Myovant Sciences Ltd: Overview

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

Myovant Sciences Ltd is into pharmaceutical and healthcare industry that develops therapeutics to treat androgen-sensitive prostate cancer. The company is headquartered in London, England, the UK.

 Gain a 360-degree view of Myovant Sciences Ltd and make more informed decisions for your business Gain a 360-degree view of Myovant Sciences Ltd and make more informed decisions for your business Register your interest
Headquarters United Kingdom
Address Ste 1 3rd Fl, 11/12 St. James's Square, London, SW1Y4LB
Website myovant.com
Telephone 44 20 74003351
No of Employees 579
Industry Pharmaceuticals and Healthcare
Revenue (2022) $231.0M
   
   
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Register your interest

Myovant Sciences Ltd premium industry data and analytics

50+

Catalyst Calendar

Proactively evaluate Myovant Sciences Ltd’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

30+

Clinical Trials

Determine Myovant Sciences Ltd go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

8

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

3

Pipeline Drugs

Identify which of Myovant Sciences Ltd’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

2

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

2

Marketed Drugs

Understand Myovant Sciences Ltd’s commercialized product portfolio to stay one step ahead of the market.

Image for loader
Executives
Name Position Board Since Age
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Gain insight into Myovant Sciences Ltd key executives to enhance your sales strategy Gain insight into Myovant Sciences Ltd key executives to enhance your sales strategy Register your interest
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?